Posts by The Block Firm
K.C. Pharmaceuticals Eye Drop Recall – Case Investigation
The Block Firm is beginning to investigate the K.C. Pharmaceuticals eye drop recall and potential claims for those who have been affected. The FDA has issued a warning letter to K.C. Pharmaceuticals, Inc., a Pomona, California manufacturer of sterile eye drop products, citing serious, ongoing failures in the way the company makes its products. On…
Read MoreCase Update: Butler v. Glenmark Pharmaceuticals Inc., USA
FDA Issues New Warning Letter Over Continued Manufacturing Failures The FDA has again flagged Glenmark Pharmaceuticals for serious manufacturing violations tied to its extended-release potassium chloride capsules. This is the same product at the center of our class action, Butler v. Glenmark Pharmaceuticals Inc., USA. On July 11, 2025, the FDA sent Glenmark Pharmaceuticals Limited a…
Read MoreAppleCare Class Action Update
The Block Firm continues to pursue its class action against Apple due to the company’s failure to cancel and refund AppleCare charges after consumers traded in or returned iPhones and other Apple devices to Apple and its authorized resellers. [Read Complaint Here.] Have You Received a Refund or Notice From Apple? Some customers have started…
Read MoreStrides Testosterone Gel Class Action Settlement
The Block Firm’s class action lawsuit, Painter, et al. v. Strides Pharma, Inc., has reached a preliminary settlement in the U.S. District Court for the Southern District of New York (Case No. 7:25-cv-4189-NSR). The lawsuit alleges that Strides manufactured testosterone gel containing the carcinogen benzene, and seeks economic damages on behalf of patients who purchased Strides…
Read MoreFinal Approval Granted in Breckenridge Class Action Settlement
The Block Firm is pleased to share that the U.S. District Court for the District of New Jersey has granted final approval of the nationwide class action settlement in The Block Firm’s case against Breckenridge Pharmaceutical, Inc., marking a successful resolution for consumers who purchased carcinogen-contaminated duloxetine (generic Cymbalta) produced by Breckenridge Pharmaceuticals. This approval follows…
Read MoreCourt Affirms Due Process: Victory for Tiny House Nonprofit in Georgia
The Block Firm is proud to support as local counsel our friends and the brilliant lawyers at the Institute for Justice. Today, the team earned a major win for our client, a non-profit dedicated to building tiny houses for lower-income workers in Northwest Georgia. As the Court ruled, “the government may not mislead parties to…
Read MoreFederal Court Denies Apple’s Motion to Dismiss in The Block Firm’s AppleCare Class Action
In a significant development in our firm’s lawsuit against Apple over its handling of AppleCare+ charges, a federal judge in the Northern District of California denied Apple’s attempt to dismiss the case, allowing key claims to move forward- including breach of contract, conversion, and civil theft under California law. The Issue Our clients allege that…
Read MoreFDA Issues Warning Letter to Glenmark Pharmaceuticals – July 11, 2025
On July 11, 2025, the U.S. Food and Drug Administration (FDA) issued a new warning letter to Glenmark Pharmaceuticals Limited. This letter outlines continuing significant violations of current good manufacturing practices (CGMP), particularly related to the production of extended-release potassium chloride capsules. Key Issues Identified by the FDA Inadequate Investigations: Glenmark failed to properly investigate…
Read MoreThe Block Firm Secures Preliminary Approval in Pharmaceutical Class Action Settlement
We are pleased to announce that the United States District Court for the District of New Jersey has granted preliminary approval of the proposed class action settlement in Butler v. Breckenridge Pharmaceutical Inc. This case involves a recall of millions of duloxetine pills (generic Cymbalta) containing carcinogens known as nitrosamines. This preliminary approval is an…
Read MoreThe Block Firm Files Class Action Against Strides Pharma Over Benzene-Contaminated Testosterone Gel
The Block Firm has filed a class action lawsuit against Strides Pharma, alleging that the company distributed testosterone gel products contaminated with benzene, a known carcinogen. This legal action follows Strides Pharma’s recall of the affected products and aims to seek justice for consumers who may have been exposed to harmful substances. Background Benzene is…
Read More